High LIN28A expressing ovarian cancer cells secrete exosomes that induce invasion and migration in HEK293 cells

BioMed Research International

Volumn 2015, Issue , 2015, Pages

  Enriquez, Vanessa A ^a   Cleys, Ellane R ^a   Da Silveira, Juliano C ^b   Spillman, Monique A ^c   Winger, Quinton A ^a   Bouma, Gerrit J ^a  

^a Veterinary Dentistry and Oral Surgery   (United States)

^b UNIVERSITY OF SÃO PAULO   (Brazil)

^c UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; LIN28A PROTEIN; LIN28B PROTEIN; MICRORNA; RNA; RNA BINDING PROTEIN; UNCLASSIFIED DRUG; LIN28B PROTEIN, HUMAN;

ARTICLE; CELL FUNCTION; CELL MIGRATION; CELL TRANSFORMATION; CONTROLLED STUDY; EPITHELIAL MESENCHYMAL TRANSITION; EXOSOME; FEMALE; GENE EXPRESSION; HEK293 CELL LINE; HUMAN; HUMAN CELL; OUTCOME ASSESSMENT; OVARY CANCER; PROTEIN EXPRESSION; STEM CELL; TUMOR GROWTH; TUMOR INVASION; BIOSYNTHESIS; CELL MOTION; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; OVARY TUMOR; PATHOLOGY;

CELL MOVEMENT; CELL TRANSFORMATION, NEOPLASTIC; EPITHELIAL-MESENCHYMAL TRANSITION; EXOSOMES; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HEK293 CELLS; HUMANS; MICRORNAS; NEOPLASM INVASIVENESS; OVARIAN NEOPLASMS; RNA-BINDING PROTEINS;

EID: 84947561403     PISSN: 23146133     EISSN: 23146141     Source Type: Journal    
DOI: 10.1155/2015/701390     Document Type: Article

References (49)

1. A. Jemal, R. Siegel, E. Ward et al., "Cancer statistics, 2006," CA: A Cancer Journal for Clinicians, vol. 56, no. 2, pp. 106-130, 2006.
2. H. Valadi, K. Ekström, A. Bossios, M. Sjöstrand, J. J. Lee, and J. O. Lötvall, "Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells," Nature Cell Biology, vol. 9, no. 6, pp. 654-659, 2007.
3. K. Al-Nedawi, B. Meehan, J. Micallef et al., "Intercellular transfer of the oncogenic receptor EGFRvIII by microvesicles derived from tumour cells," Nature Cell Biology, vol. 10, no. 5, pp. 619-624, 2008.
4. J. Skog, T. Würdinger, S. van Rijn et al., "Glioblastoma micro-vesicles transport RNA and proteins that promote tumour growth and provide diagnostic bio-markers," Nature Cell Biology, vol. 10, no. 12, pp. 1470-1476, 2008.
5. D. D. Taylor and C. Gercel-Taylor, "MicroRNA signatures of tumor-derived exosomes as diagnostic biomarkers of ovarian cancer," Gynecologic Oncology, vol. 110, no. 1, pp. 13-21, 2008.
6. T. Pisitkun, R.-F. Shen, and M. A. Knepper, "Identifcation and proteomic profling of exosomes in human urine," Proceedings of the National Academy of Sciences of the United States of America, vol. 101, no. 36, pp. 13368-13373, 2004.
7. M. Gonzalez-Begne, B. Lu, X. Han et al., "Proteomic analysis of human parotid gland exosomes by multidimensional protein identifcation technology (MudPIT)," Journal of Proteome Research, vol. 8, no. 3, pp. 1304-1314, 2009.
8. M.-P. Caby, D. Lankar, C. Vincendeau-Scherrer, G. Raposo, and C. Bonnerot, "Exosomal-like vesicles are present in human blood plasma," International Immunology, vol. 17, no. 7, pp. 879-887, 2005.
9. J. L. Gatti, S. Métayer, M. Belghazi, F. Dacheux, and J. L. Dacheux, "Identifcation, proteomic profling, and origin of ram epididymal fuid exosome-like vesicles," Biology of Reproduction, vol. 72, no. 6, pp. 1452-1465, 2005.
10. S. Keller, C. Rupp, A. Stoeck et al., "CD24 is a marker of exo-somes secreted into urine and amniotic fuid," Kidney International, vol. 72, no. 9, pp. 1095-1102, 2007.
11. J. C. da Silveira, D. N. R. Veeramachaneni, Q. A. Winger, E. M. Carnevale, and G. J. Bouma, "Cell-secreted vesicles in equine ovarian follicular fuid contain mirnas and proteins: a possible new form of cell communication within the ovarian follicle," Biology of Reproduction, vol. 86, no. 3, article 71, 2012.
12. F. Andre, N. E. C. Schartz, M. Movassagh et al., "Malignant efusions and immunogenic tumour-derived exosomes," The Lancet, vol. 360, no. 9329, pp. 295-305, 2002.
13. P. Torregrosa Paredes, J. Esser, C. Admyre et al., "Bronchoalveo-lar lavage fuid exosomes contribute to cytokine and leukotriene production in allergic asthma," Allergy, vol. 67, no. 7, pp. 911-919, 2012.
14. A. Sternjak, S. Blä, S. Metzkow, P. Jungblut, G. Burmester, and S. K. Skriner, "Immunomic analysis of syovial fuid exosomes of rheumatic diseases patients," Arthritis Research & Terapy, vol. 4, supplement 1, article 75, 2002.
15. C. Admyre, S. M. Johansson, K. R. Qazi et al., "Exosomes with immunemodulatoryfeatures are presentinhuman breast milk," The Journal of Immunology, vol. 179, no. 3, pp. 1969-1978, 2007.
16. A. Ginestra, M. D. la Placa, F. Saladino, D. Cassara, H. Nagase, and M. L. Vittorelli, "The amount and proteolytic content of vesicles shed by human cancer cell lines correlates with their in vitro invasiveness," Anticancer Research, vol. 18, no. 5, pp. 3433-3437, 1998.
17. A. Clayton, J. P. Mitchell, J. Court, M. D. Mason, and Z. Tabi, "Human tumor-derived exosomes selectively impair lymphocyte responses to interleukin-2," Cancer Research, vol. 67, no. 15, pp. 7458-7466, 2007.
18. A. M. Friel, C. Corcoran, J. Crown, and L. O'Driscoll, "Relevance of circulating tumor cells, extracellular nucleic acids, and exosomes in breast cancer," Breast Cancer Research and Treatment, vol. 123, no. 3, pp. 613-625, 2010.
19. X. Zhong, G. Coukos, and L. Zhang, "miRNAs in human cancer," Methods in Molecular Biology, vol. 822, pp. 295-306, 2012.
20. T. A. Farazi, J. I. Hoell, P. Morozov, and T. Tuschl, "MicroRNAs in human cancer," Advances in Experimental Medicine and Biology, vol. 774, pp. 1-20, 2013.
21. G. A. Calin and C. M. Croce, "MicroRNA signatures in human cancers," Nature Reviews Cancer, vol. 6, no. 11, pp. 857-866, 2006.
22. L. Zhang, S. Volinia, T. Bonome et al., "Genomic and epige-netic alterations deregulate microRNA expression in human epithelial ovarian cancer," Proceedings of the National Academy of Science USA, vol. 105, no. 19, pp. 7004-7009, 2008.
23. Y. Cai, X. Yu, S. Hu, and J. Yu, "A brief review on the mechanisms of miRNA regulation," Genomics, Proteomics & Bioinformatics, vol. 7, no. 4, pp. 147-154, 2009.
24. D. P. Bartel, "MicroRNAs: target recognition and regulatory functions," Cell, vol. 136, no. 2, pp. 215-233, 2009.
25. K. Ruan, X. Fang, and G. Ouyang, "MicroRNAs: novel regulators in the hallmarks of human cancer," Cancer Letters, vol. 285, no. 2, pp. 116-126, 2009.
26. Y. Nam, C. Chen, R. I. Gregory, J. J. Chou, and P. Sliz, "Molecular basis for interaction of let-7 microRNAs with Lin28," Cell, vol. 147, no. 5, pp. 1080-1091, 2011.
27. E. Piskounova, S. R. Viswanathan, M. Janas et al., "Determinants of microRNA processing inhibition by the developmentally regulated RNA-binding protein Lin28," The Journal of Biological Chemistry, vol. 283, no. 31, pp. 21310-21314, 2008.
28. S. R. Viswanathan, J. T. Powers, W. Einhorn et al., "Lin28 promotes transformation and is associated with advanced human malignancies," Nature Genetics, vol. 41, no. 7, pp. 843-848, 2009.
29. X. Zhong, N. Li, S. Liang, Q. Huang, G. Coukos, and L. Zhang, "Identifcation of microRNAs regulating reprogramming factor LIN28 in embryonic stem cells and cancer cells," Journal of Biological Chemistry, vol. 285, no. 53, pp. 41961-41971, 2010.
30. S. Peng, N. J. Maihle, and Y. Huang, "Pluripotency factors Lin28 and Oct4 identify a sub-population of stem cell-like cells in ovarian cancer," Oncogene, vol. 29, no. 14, pp. 2153-2159, 2010.
31. J. Bénard, J. da Silva, M.-C. de Blois et al., "Characterization of a human ovarian adenocarcinoma line, IGROV1, in tissue culture and in nude mice," Cancer Research, vol. 45, no. 10, pp. 4970-4979, 1985.
32. L. Lee, R. P. Hellendall, Y. Wang et al., "IL-8 reduced tumorigeni-city of human ovarian cancer in vivo due to neutrophil infltra-tion," The Journal of Immunology, vol. 164, no. 5, pp. 2769-2775, 2000.
33. C. Lässer, M. Eldh, and J. Lötvall, "Isolation and characterization of RNA-containing exosomes," Journal of Visualized Experiments, no. 59, Article ID e3037, 2012.
34. J.-K. Lee, S.-R. Park, B.-K. Jung et al., "Exosomes derived from mesenchymal stem cells suppress angiogenesis by down-regulating VEGF expression in breast cancer cells," PLoS ONE, vol. 8, no. 12, Article ID e84256, 2013.
35. E. Piskounova, C. Polytarchou, J. E. Tornton et al., "Lin28A and Lin28B inhibit let-7 MicroRNA biogenesis by distinct mechanisms," Cell, vol. 147, no. 5, pp. 1066-1079, 2011.
36. M. T. Le, P. Hamar, C. Guo et al., "miR-200-containing extracellular vesicles promote breast cancer cell metastasis," Journal of Clinical Investigation, vol. 124, no. 12, pp. 5109-5128, 2014.
37. M. Y. Fong, W. Zhou, L. Liu et al., "Breast-cancer-secreted miR-122 reprograms glucose metabolism in premetastatic niche to promote metastasis," Nature Cell Biology, vol. 17, no. 2, pp. 183-194, 2015.
38. J. Yu, M. A. Vodyanik, K. Smuga-Otto et al., "Induced pluripo-tent stem cell lines derived from human somatic cells," Science, vol. 318, no. 5858, pp. 1917-1920, 2007.
39. A. K. Mitra, M. Zillhardt, Y. Hua et al., "MicroRNAs reprogram normal fbroblasts into cancer-associated fbroblasts in ovarian cancer," Cancer Discovery, vol. 2, no. 12, pp. 1100-1108, 2012.
40. R. Ambasudhan, M. Talantova, R. Coleman et al., "Direct reprogramming of adult human fbroblasts to functional neurons under defned conditions," Cell Stem Cell, vol. 9, no. 2, pp. 113-118, 2011.
41. R. Schickel, B. Boyerinas, S. M. Park, and M. E. Peter, "MicroR-NAs: key players in the immune system, diferentiation, tumori-genesis and cell death," Oncogene, vol. 27, no. 45, pp. 5959-5974, 2008.
42. M. V. Iorio, R. Visone, G. di Leva et al., "MicroRNA signatures in human ovarian cancer," Cancer Research, vol. 67, no. 18, pp. 8699-8707, 2007.
43. N. Yang, S. Kaur, S. Volinia et al., "MicroRNA microarray identifes Let-7i as a novel biomarker and therapeutic target in human epithelial ovarian cancer," Cancer Research, vol. 68, no. 24, pp. 10307-10314, 2008.
44. T. Kobayashi, E. Stang, K. S. Fang, P. de Moerloose, R. G. Parton, and J. Gruenberg, "A lipid associated with the antiphospholipid syndrome regulates endosome structure and function," Nature, vol. 392, no. 6672, pp. 193-197, 1998.
45. K. A. O'Donnell, E. A. Wentzel, K. I. Zeller, C. V. Dang, and J. T. Mendell, "c-Myc-regulated microRNAs modulate E2F1 expression," Nature, vol. 435, no. 7043, pp. 839-843, 2005.
46. L. He, J. M. Tomson, M. T. Hemann et al., "A microRNA polycistron as a potential human oncogene," Nature, vol. 435, no. 7043, pp. 828-833, 2005.
47. S.-M. Park, A. B. Gaur, E. Lengyel, and M. E. Peter, "The miR-200 family determines the epithelial phenotype of cancer cells by targeting the E-cadherin repressors ZEB1 and ZEB2," Genes and Development, vol. 22, no. 7, pp. 894-907, 2008.
48. M. Ouzounova, T. Vuong, P.-B. Ancey et al., "MicroRNA miR-30 family regulates non-attachment growth of breast cancer cells," BMC Genomics, vol. 14, article 139, 2013.
49. A. Grimson, K. K.-H. Farh, W. K. Johnston, P. Garrett-Engele, L. P. Lim, and D. P. Bartel, "MicroRNA targeting specifcity in mammals: determinants beyond seed pairing," Molecular Cell, vol. 27, no. 1, pp. 91-105, 2007.